Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

EGFR inhibitors can cause yellowish skin eruptions.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Cetuximab can cause skin cysts after acne-like eruptions.

A new therapy for a skin blistering condition has not been developed yet.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Corin speeds up wound healing by helping skin cells move and grow.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

DA-9401 helps protect rat testis from finasteride damage.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The document's conclusion cannot be provided because the document is not available or cannot be read.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Baricitinib is effective as a treatment for severe hair loss.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

CMADK reduces hair damage from bleaching and permanent waving.